Dr. Reddy's Laboratories Ltd. (DRREDDY)
BSE
Real-time Data
03:45 AM
Day's Range
1,179.2552 wk Range
1,110.40Overview - DRREDDY - Dr. Reddy's Laboratories Ltd.
Key Statistics
Valuation
Enterprise Value
1.02T
P/E (Trailing)
‪17.60‬
P/E (Forward)
‪21.74‬
PEG Ratio
‪21.74‬
Price / Sales (TTM)
‪2.87‬
Price / Book
‪2.67‬
EV / EBITDA
‪12.09‬
Profitability
Gross Margin
‪46.51%‬
Profit Margin
‪16.36%‬
Operating Margin
‪16.42%‬
Return on Assets
‪7.95%‬
Return on Equity
‪16.10%‬
Ownership
Shares Outstanding
832.98M
Float
600.35M
Held by Insiders
‪29.45%‬
Held by Institutions
‪51.84%‬
Price stats
Beta
‪0.29‬
50-Day Avg
‪1,241.81‬
200-Day Avg
‪1,252.17‬
Dividends
Payout Ratio
‪11.79%‬
Frequency
Annual
Analyst Consensus
38 analysts
Average price target
‪₹ 1,313.16‬Market Cap - DRREDDY - Dr. Reddy's Laboratories Ltd.
Peers - DRREDDY - Dr. Reddy's Laboratories Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BSE.
- DRREDDYBSEDr. Reddy's Laboratories Ltd.994.50BMarket Cap-6.92%52-week change17.61P/E (Trailing)‪16.36%‬Profit Margin
- DIVISLABBSEDivi's Laboratories Ltd.2.25TMarket Cap+27.45%52-week change87.72P/E (Trailing)‪26.04%‬Profit Margin
- CIPLABSECipla Ltd.1.14TMarket Cap-11.64%52-week change25.39P/E (Trailing)‪16.25%‬Profit Margin
- LAURUSLABSBSELaurus Labs Ltd.1.00TMarket Cap+54.36%52-week change89.19P/E (Trailing)‪15.04%‬Profit Margin
- LUPINBSELupin Ltd.993.90BMarket Cap+12.76%52-week change23.24P/E (Trailing)‪17.47%‬Profit Margin
- MANKINDBSEMankind Pharma Ltd.977.56BMarket Cap-2.49%52-week change48.14P/E (Trailing)‪13.85%‬Profit Margin
- AUROPHARMABSEAurobindo Pharma Ltd.936.28BMarket Cap+35.16%52-week change27.51P/E (Trailing)‪10.52%‬Profit Margin
Profile Summary - DRREDDY - Dr. Reddy's Laboratories Ltd.
About
Dr. Reddy's Laboratories Ltd. is a renowned player in the pharmaceutical industry, engaged in the development and manufacture of cost-effective and innovative medicines globally. The company is known for its diverse product portfolio, which includes generic drugs, active pharmaceutical ingredients (APIs), and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
